Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease

被引:163
|
作者
Dorsey, E. Ray [1 ]
Venkataraman, Vinayak [1 ]
Grana, Matthew J. [3 ]
Bull, Michael T. [3 ]
George, Benjamin P. [6 ]
Boyd, Cynthia M. [2 ]
Beck, Christopher A. [4 ]
Rajan, Balaraman [5 ]
Seidmann, Abraham [5 ]
Biglan, Kevin M. [3 ]
机构
[1] Johns Hopkins Med, Dept Neurol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med, Dept Med, Baltimore, MD 21287 USA
[3] Univ Rochester, Med Ctr, Dept Neurol, New York, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, New York, NY USA
[5] Univ Rochester, William E Simon Grad Sch Business Adm, New York, NY USA
[6] Univ Rochester, Sch Med & Dent, New York, NY USA
关键词
DEEP-BRAIN-STIMULATION; CARE; TELEMEDICINE; SATISFACTION; VALIDATION;
D O I
10.1001/jamaneurol.2013.123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention: Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P=.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P=.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 50 条
  • [41] Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease
    Leroi, Iracema
    Overshott, Ross
    Byrne, E. Jane
    Daniel, Emily
    Burns, Alistair
    MOVEMENT DISORDERS, 2009, 24 (08) : 1217 - 1221
  • [42] Methylphenidate improves fatigue scores in Parkinson disease:: A randomized controlled trial
    Mendonca, Dan A.
    Menezes, Krishe
    Jog, Mandar S.
    MOVEMENT DISORDERS, 2007, 22 (14) : 2070 - 2076
  • [43] Randomized-placebo controlled trial of donepezil in Parkinson's disease
    Leroi, I.
    Brandt, J.
    Reich, S. G.
    Lyketsos, C. G.
    Grill, S.
    Thompson, R.
    Marsh, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 289 - 290
  • [44] Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
    Watts, R. L.
    Jankovic, J.
    Waters, C.
    Rajput, A.
    Boroojerdi, B.
    Rao, J.
    NEUROLOGY, 2007, 68 (04) : 272 - 276
  • [45] Pilot randomized controlled trial of telemedicine for individuals with Parkinson's disease
    Dorsey, R.
    Deuel, L.
    Appler, A.
    Eason, S.
    George, B.
    Joseph, A.
    Miller, D.
    Polanowicz, J.
    Reminick, J.
    Smith, S.
    Viti, L.
    Voss, T.
    Biglan, K.
    MOVEMENT DISORDERS, 2009, 24 : S261 - S261
  • [46] Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
    Troche, Michelle S.
    Curtis, James A.
    Sevitz, Jordanna S.
    Dakin, Avery E.
    Perry, Sarah E.
    Borders, James C.
    Grande, Alessandro A.
    Mou, Yuhan
    Vanegas-Arroyave, Nora
    Hegland, Karen W.
    MOVEMENT DISORDERS, 2023, 38 (02) : 201 - 211
  • [47] Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
    van der Marck, Marjolein A.
    Bloem, Bastiaan R.
    Borm, George F.
    Overeem, Sebastiaan
    Munneke, Marten
    Guttman, Mark
    MOVEMENT DISORDERS, 2013, 28 (05) : 605 - 611
  • [48] A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease
    Morris, Meg E.
    Menz, Hylton B.
    McGinley, Jennifer L.
    Watts, Jennifer J.
    Huxham, Frances E.
    Murphy, Anna T.
    Danoudis, Mary E.
    Iansek, Robert
    NEUROREHABILITATION AND NEURAL REPAIR, 2015, 29 (08) : 777 - 785
  • [49] Bright light therapy for depression in Parkinson disease A randomized controlled trial
    Rutten, Sonja
    Vriend, Chris
    Smit, Jan H.
    Berendse, Henk W.
    van Someren, Eus J. W.
    Hoogendoorn, Adriaan W.
    Twisk, Jos W. R.
    van der Werf, Ysbrand D.
    van den Heuvel, Odile A.
    NEUROLOGY, 2019, 92 (11) : E1145 - E1156
  • [50] Aquatic Exercise Therapy for People With Parkinson Disease: A Randomized Controlled Trial
    Carroll, Louise M.
    Volpe, Daniele
    Morris, Meg E.
    Saunders, Jean
    Clifford, Amanda M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2017, 98 (04): : 631 - 638